EyePoint Pharmaceuticals (EYPT) Stock Forecast for 2027. Eypt Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?

At historically low interest rates, refinancing can seem tempting; but applications for refinance could be denied for various reasons. Underwriters need assurances that…

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Forecast for 2027. Eypt Shares Prediction

Updated: March 26, 2024 (09:51)

Sector: Healthcare

The share price of EyePoint Pharmaceuticals, Inc. (EYPT) now

What analysts predict: $43.67
52-week High/Low: $30.99 / $2.72

50/200 Day Moving Average: $25.58 / $14.69

This figure corresponds to the Average Price over the previous 50/200 days. For EyePoint Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For EyePoint Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in EyePoint Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the EyePoint Pharmaceuticals stock price in 2027. How much will one EyePoint Pharmaceuticals share be worth in 2027? Is it worth taking profit / loss on EYPT stock now or waiting? What are analysts' forecasts for EyePoint Pharmaceuticals stock?

We forecast EyePoint Pharmaceuticals stock performance using neural networks based on historical data on EYPT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

EyePoint Pharmaceuticals, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for EyePoint Pharmaceuticals analysts is $43.67. Today 200 Day Moving Average is the support level (14.69 $). 50 Day Moving Average is the support level (25.58 $).




Historical and forecast chart of EyePoint Pharmaceuticals, Inc. stock

The chart below shows the historical price of EyePoint Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EYPT stock price can be found in the table below.


EyePoint Pharmaceuticals (EYPT) Forecast for 2027

Month Target Pes. Opt. Vol., %
Jan 24.95 21.63 28.55 24.24 %
Feb 22.63 19.75 24.82 20.44 %
Mar 21.17 20.00 24.18 17.30 %
Apr 24.95 22.24 28.55 22.08 %
May 26.37 24.21 27.47 11.85 %
Jun 29.12 27.52 33.00 16.60 %
Jul 26.69 25.68 30.64 16.22 %
Aug 22.78 21.70 25.90 16.21 %
Sep 24.17 21.97 25.46 13.71 %
Oct 25.87 21.94 27.00 18.75 %
Nov 27.98 24.42 30.96 21.12 %
Dec 25.70 21.79 29.26 25.53 %

EyePoint Pharmaceuticals information and performance

EyePoint Pharmaceuticals Address

480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US

Market Capitalization: 1 109 234 000 $

Market capitalization of the EyePoint Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYPT shares in the company outstanding by the market price of one share.

EBITDA: -73 402 800 $

EBITDA of EyePoint Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.332
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 16.98

Enterprise Value (EV) /Revenue

EV To EBITDA: -11.33

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49830800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

EyePoint Pharmaceuticals price target for 2027 by month


Target values for the price of one EyePoint Pharmaceuticals share for Jan 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Jan 2027 is: 24.95.
In Jan, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 24.240% volatility is expected.
Pessimistic target level: 21.63
Optimistic target level: 28.55

Target values for the price of one EyePoint Pharmaceuticals share for Feb 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Feb 2027 is: 22.63.
In Feb, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 20.440% volatility is expected.
Pessimistic target level: 19.75
Optimistic target level: 24.82

Target values for the price of one EyePoint Pharmaceuticals share for Mar 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Mar 2027 is: 21.17.
In Mar, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 17.295% volatility is expected.
Pessimistic target level: 20.00
Optimistic target level: 24.18

Target values for the price of one EyePoint Pharmaceuticals share for Apr 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Apr 2027 is: 24.95.
In Apr, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 22.081% volatility is expected.
Pessimistic target level: 22.24
Optimistic target level: 28.55

Target values for the price of one EyePoint Pharmaceuticals share for May 2027.

The weighted average target price per EyePoint Pharmaceuticals share in May 2027 is: 26.37.
In May, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 11.854% volatility is expected.
Pessimistic target level: 24.21
Optimistic target level: 27.47

Target values for the price of one EyePoint Pharmaceuticals share for Jun 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Jun 2027 is: 29.12.
In Jun, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.602% volatility is expected.
Pessimistic target level: 27.52
Optimistic target level: 33.00

Target values for the price of one EyePoint Pharmaceuticals share for Jul 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Jul 2027 is: 26.69.
In Jul, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.217% volatility is expected.
Pessimistic target level: 25.68
Optimistic target level: 30.64

Target values for the price of one EyePoint Pharmaceuticals share for Aug 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Aug 2027 is: 22.78.
In Aug, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.212% volatility is expected.
Pessimistic target level: 21.70
Optimistic target level: 25.90

Target values for the price of one EyePoint Pharmaceuticals share for Sep 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Sep 2027 is: 24.17.
In Sep, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 13.710% volatility is expected.
Pessimistic target level: 21.97
Optimistic target level: 25.46

Target values for the price of one EyePoint Pharmaceuticals share for Oct 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Oct 2027 is: 25.87.
In Oct, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 18.751% volatility is expected.
Pessimistic target level: 21.94
Optimistic target level: 27.00

Target values for the price of one EyePoint Pharmaceuticals share for Nov 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Nov 2027 is: 27.98.
In Nov, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 21.122% volatility is expected.
Pessimistic target level: 24.42
Optimistic target level: 30.96

Target values for the price of one EyePoint Pharmaceuticals share for Dec 2027.

The weighted average target price per EyePoint Pharmaceuticals share in Dec 2027 is: 25.70.
In Dec, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 25.529% volatility is expected.
Pessimistic target level: 21.79
Optimistic target level: 29.26



EyePoint Pharmaceuticals (EYPT) stock dividend

EyePoint Pharmaceuticals last paid dividends on 01/01/1970. The next scheduled payment will be on 12/09/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.